Mydocalm by Gedeon Richter is the original muscle relaxant centrally acting through nicotinic receptor blockade at the spinal level. The injectable form combines tolperisone (100 mg/ml) with a small dose of lidocaine (2.5 mg/ml) that reduces injection-site pain.
Composition
Why tolperisone is used
Why Mydocalm differs from classic relaxants
Unlike baclofen or tizanidine, tolperisone does not cause pronounced sedation or muscle weakness at therapeutic doses - it works selectively on hyperactive spinal reflexes. Patients usually keep daily activity, which is why it is a common first-line choice for working adults.
Administration
Product features
Contraindications
Hypersensitivity to tolperisone, lidocaine or components; myasthenia gravis; pregnancy and breastfeeding - only under medical supervision. Children under prescription.
FAQ
Tolperisone injections can be painful; the small lidocaine dose (2.5 mg) numbs the injection site locally without systemic anesthetic effect.
Sedation is minimal compared to baclofen/tizanidine. Rarely - mild weakness or dizziness; driving response is individual.
Injections give faster onset for acute spasm; tablets are for longer courses and maintenance. Physicians often start with injections and switch to tablets.
Yes - the classic pairing for back pain is a muscle relaxant plus NSAID; the combination works on different targets. Final scheme is set by the physician.
Injectable effect starts within minutes after IV and tens of minutes after IM; full relaxation effect is evaluated over the course.
Ask a question or inquire about delivery to your country


